HOTH (STOCKS)
Hoth Therapeutics, Inc. Common Stock
$0.514300
-0.001400 (-0.27%)
Prev close: $0.515700
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robbie Knie
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9.76M
- Employees
- 3
- P/E (TTM)
- -0.57
- P/B (TTM)
- 1.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.16 | $-0.10 | -0.0580 | -56.86% |
|
Sep 2025 (Q3)
|
$-0.30 | $-0.10 | -0.1980 | -194.12% |
|
Jun 2025 (Q2)
|
$-0.17 | $-0.14 | -0.0272 | -19.05% |
|
Mar 2025 (Q1)
|
$-0.27 | $-0.27 | -0.0048 | -1.81% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$107.95K |
| Operating Expenses | $12.36M |
| Research and Development | $5.95M |
| Other Operating Expenses | $6.41M |
| Operating Income/Loss | -$12.36M |
| Income/Loss From Continuing Operations After Tax | -$12.47M |
| Income/Loss From Continuing Operations Before Tax | -$12.47M |
| Net Income/Loss | -$12.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.90 |
| Diluted Earnings Per Share | -$0.90 |
| Basic Average Shares | 13,805,813 |
| Diluted Average Shares | 13,805,813 |
| Assets | $7.60M |
| Current Assets | $6.86M |
| Noncurrent Assets | $740.89K |
| Liabilities | $1.45M |
| Current Liabilities | $1.45M |
| Accounts Payable | $823.67K |
| Other Current Liabilities | $629.00K |
| Noncurrent Liabilities | $0.00 |
| Equity | $6.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.15M |
| Liabilities And Equity | $7.60M |
| Net Cash Flow From Operating Activities | -$9.80M |
| Net Cash Flow From Operating Activities, Continuing | -$9.80M |
| Net Cash Flow From Investing Activities | $491.46K |
| Net Cash Flow From Investing Activities, Continuing | $493.22K |
| Net Cash Flow From Financing Activities | $9.31M |
| Net Cash Flow From Financing Activities, Continuing | $9.31M |
| Exchange Gains/Losses | $1.77K |
| Net Cash Flow | -$1.77K |
| Net Cash Flow, Continuing | -$3.54K |
| Comprehensive Income/Loss | -$12.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.47M |
| Other Comprehensive Income/Loss | -$12.47M |